Back to Search
Start Over
161P Population effectiveness model of the consequences of recurrence after trastuzumab emtansine (T-DM1) treatment among U.S. patients with high-risk HER2+ early-stage breast cancer (ESBC).
- Source :
-
Annals of Oncology . 2021 Supplement 5, Vol. 32, pS430-S431. 2p. - Publication Year :
- 2021
- Subjects :
- *HER2 positive breast cancer
*TRASTUZUMAB
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 32
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 152688790
- Full Text :
- https://doi.org/10.1016/j.annonc.2021.08.442